The Biological Significance of PACAP and PACAP Receptors in Human Tumors: From Cell Lines to Cancers-Reference-Cited by-同舟云学术

The Biological Significance of PACAP and PACAP Receptors in Human Tumors: From Cell Lines to Cancers

Published:2003 Issue: Volume: Page:361-399
ISSN:1566-0729
Container-title:Pituitary Adenylate Cyclase-Activating Polypeptide
language:
Short-container-title:

Author:

Lelièvre V.,Pineau N.,Waschek J. A.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-0243-2_17

Reference254 articles.

1. Adamou JE, Aiyar N, Van Horn S, Elshourbagy NA. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem Biophys Res Comm 1995;209:385–392.

2. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WC, van Der Kwast TT, Schroder FH, Tanke HJ, van Dekken H. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features. Am J Pathol 2001;158:399–406.

3. Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC I and VPAC2 receptors in mammals. Endocrinology 1999;140:1285–1293

4. Arlt A, Grobe 0, Sieke A, Kruse ML, Folsch UR, Schmidt WE, Schafer H. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells. Oncogene 2001;20:69–76.

5. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984;44:39613969.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery;Pharmacological Reviews;2009-09

2. Small-molecule modulators of Hh and Wnt signaling pathways;Expert Opinion on Therapeutic Targets;2007-07-31

3. Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury;Blood;2006-01-15